Sarcopenia is a poor prognostic factor of castration-resistant prostate cancer treated with docetaxel therapy

BACKGROUND: Sarcopenia is a geriatric syndrome that is characterized by the gradual muscle loss and frailty in the elderly. Meanwhile, the prevalence of prostate cancer is on the rise worldwide. Mainstay treatments for metastatic prostate cancer are androgen-deprivation therapy and taxane-based chem...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohtaka, Ayako, Aoki, Hiroaki, Nagata, Masayoshi, Kanayama, Mayuko, Shimizu, Fumitaka, Ide, Hisamitsu, Tsujimura, Akira, Horie, Shigeo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Pacific Prostate Society 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6424678/
https://www.ncbi.nlm.nih.gov/pubmed/30937292
http://dx.doi.org/10.1016/j.prnil.2018.04.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6424678/
https://www.ncbi.nlm.nih.gov/pubmed/30937292
http://dx.doi.org/10.1016/j.prnil.2018.04.002

Ejemplares similares